Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. junior Avg
|
|
New words:
adult, affirmative, AI, alpha, approachstrategy, axatilamab, bear, binimetinib, bioanalytical, biosimilar, Black, Boxer, Braftovi, card, Circuit, codified, customary, cutoff, decade, decease, default, delineated, detachable, dozen, embody, encorafenib, experimental, flexibility, freestanding, implicit, isoform, Jakafi, Journal, KKC, lowest, lymphoblastic, magazine, mainstay, mBC, Mektovi, midpoint, mucosa, mutant, Notably, nurse, outbreak, overwhelmed, par, pediatric, pharmacovigilance, Piqray, precursor, prefunded, rearranged, remanded, Remission, renegotiate, repay, reset, resign, retention, ROU, Ruxolitinib, strain, subpopulation, theNational, unadjusted, upheld, weighted, xenograftsxenograft
Removed:
abatement, amortize, amounted, ascending, attaining, avelumab, benchmark, beneficiary, cancel, Citigroup, collaboratively, confirmed, contemplated, converted, create, delivering, diagnosed, DLT, EGFR, elimination, examine, explain, freely, illiquid, JPM, KHK, landscape, marketplace, mg, morbidity, Morgan, mortality, objective, Oppenheimer, overallotment, postmenopausal, preference, progressing, reconciling, redemption, resolved, restriction, returned, revaluation, salary, satisfactorily, secondary, serial, Similarly, spectrum, spend, standby, Stanley, suppressive, tradable, triple, understand, underwriting, unit
Filing tables
Filing exhibits
Related press release
Associated SNDX transcripts
SNDX similar filings
Filing view
External links